28 March 2024
THIS ANNOUNCEMENT CONTAINS INSIDE
INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU NO.
596/2014) AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE
EUROPEAN UNION (WITHDRAWAL) ACT 2018 (AS AMENDED) ("MAR"). UPON THE
PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION
SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE
PUBLIC DOMAIN.
MOLECULAR ENERGIES
PLC
("Molecular" or the "Company")
Update on IPO of Green House
Capital Group plc
Proposed cancellation of
admission of Ordinary Shares to trading on AIM
Re-registration as a Private
Limited Company
Adoption of New Articles of
Association
Notice of General
Meeting
Molecular Energies plc (AIM:
MEN), the international energy company, today announces an
update on the IPO of Green House Capital Group PLC ("Green House"),
the proposed cancellation of admission of its ordinary shares to
trading on AIM (the "Cancellation"), re-registration of the Company
as a private limited company (the "Re-registration") and the
adoption of new articles of association (the "New
Articles").
The Company has today published a
circular, extracts of which are published below, setting out the
background to and reasons for the proposed Cancellation and the
Re-registration and associated adoption of the New Articles (the
"Circular"). The Circular also contains a notice convening a
general meeting (the "General Meeting") at which Shareholders are
invited to consider and, if thought fit, approve the proposed
Cancellation and the Re-registration and associated adoption of the
New Articles.
Peter Levine, Chairman, comments: "I
take no joy in recommending the cancellation of trading in
Molecular's shares on AIM and know that this proposal will impact
many shareholders. However the primary benefits of being listed are
to avail oneself of access to capital, the ability to utilise one's
shares as currency and enjoying the reputational boost of being on
the London Stock Exchange. Molecular no longer receives any of
those benefits and so can no longer justify the disproportionately
high costs of remaining listed. As a Group its interests are best
served by turning to the private arena where Molecular can
regenerate away from the microscope and constraints of the public
markets yet avail itself of funding and exit opportunities in some
ways more flexible and abundant than remaining as a small public
company on the London market.
Since I do understand the disappointment that this will cause
and which I wholeheartedly share, whilst making no commitment to do
so, I do not rule out in the fullness of time and subject to
de-listing and on becoming a private company making proposals to
buy the shares of certain of those holders who either do not wish
or are unable to be invested in a private
business.
My
consideration in this direction reflects my conviction in the value
of Molecular as a whole and of the new businesses that we continue
to generate within the Company which the London market clearly does
not recognise. I am confident that Molecular and its various
businesses will thrive once again as a private enterprise with my
continued support and invite any holders so minded to continue the
journey alongside. In return shareholders can be assured that all
who remain invested in whatever size will be dealt with fairly and
will benefit from the openness in relation to shareholder
communications through our website, social media and other
channels, that we have always sought to
apply."
UPDATE ON IPO OF GREEN HOUSE CAPITAL GROUP
PLC
The Board has reconsidered the
potential merits of the IPO of its 75 per cent. owned carbon
removal and mitigation subsidiary, Green House Capital Group plc.
The Board takes the view given the considerations in relation to
Molecular outlined below and the ongoing adverse sentiment
affecting the London capital markets that an IPO of this business
at its early stage of development is not in the best interests of
the Company or its Shareholders at the current time. The Directors
will in due course review options in relation to this independently
run group as this business becomes more mature sheltered from the
public markets. This may include separately and privately funding
parts of the group as may be appropriate.
DETAILS OF THE PROPOSED CANCELLATION AND
RE-REGISTRATION
The Directors have conducted an
assessment of the benefits and drawbacks to the Company and its
Shareholders of retaining its quotation on AIM, and believe that
Cancellation is in the best interests of the Company and its
Shareholders as a whole.
In reaching this conclusion, the
Directors have considered the adverse share price performance of
the Company, its current market capitalisation, the perception of
the Company on AIM versus its potential, and the various potential
sources of capital available to the Company to fund its medium term
growth plans. In particular and without limit thereto, the
Directors consider:
▪
that despite the best and continual efforts of the
Company to set forth its compelling investment case, its share
price has continued to fall to a level that the Board believes is
far removed from the underlying value of the Group. The Board
considers that the reasons for this include that the Company
operates and invests in territories (e.g. the southern cone of
South America) that the London capital markets does not prioritise
or fully comprehend and what the Directors perceive as the current
dysfunction of the London markets with regard to small/micro cap
companies. The Board believes that the disconnected market value is
damaging to the reputation of the Company as it seeks to engage
partners and grow its business. Accordingly, the Board believes
that Company's growth prospects are more readily accessible and
managed in a private market environment;
▪
that the continued quotation on AIM is thus
unlikely to provide the Company with significantly wider access to
capital than the funding options it already has. The Directors
believe that an equity fundraise for the purpose of either
expansion or acquisition through the public markets would not
necessarily be available to the Company in the near or medium term
or if it were the Directors would not be able to recommend the
likely dilutive impact to existing shareholders. Further, the
Company's existing major shareholder has indicated that he is
presently unwilling to provide further capital support to the
Company on an ongoing basis in the event that its shares remain
admitted to trading on AIM. Accordingly, the Board is of the view
that there may be greater opportunities to raise additional capital
in the private markets than remaining as a listed
business;
▪
there has been limited liquidity in the Ordinary
Shares for some time and, consequently, the admission of the
Ordinary Shares to trading on AIM does not necessarily offer
investors the opportunity to trade in meaningful volumes or with
frequency within an active market. With low trading volumes, the
Company's share price can move and has moved up or down
significantly following trades of disproportionately small volumes
of Ordinary Shares. In the opinion of the Directors, the volatile
share price is detrimental to the perception of the Group amongst
customers, suppliers and other partners, which, in turn, has the
potential to negatively impact its product development, staff
incentives and morale and industry reputation;
▪
the considerable management
time, cost and the legal and regulatory burden associated with
maintaining the Company's admission to trading on AIM is, in the
Directors' opinion and in the light of the above, disproportionate
to the benefits of the Company's continued admission to trading on
AIM. Given the lower costs associated with private limited company
status, it is estimated that the Cancellation and Re-registration
will materially reduce the Company's recurring administrative and
adviser costs by approximately £500,000 per annum, which the
Directors believe can be better spent supporting growth in the
Group's business.
Following careful consideration, the
Directors therefore believe that it is in the best interests of the
Company and Shareholders as a whole to seek the proposed
Cancellation and Re-registration at the earliest
opportunity.
To be passed, the resolution in
respect of the Cancellation requires, pursuant to Rule 41 of the
AIM Rules, the approval of not less than 75 per cent. of the votes
cast by Shareholders at the General Meeting. The resolution to
approve the Re-registration and the adoption of New Articles also
requires the approval of not less than 75 per cent. of the votes
cast by shareholders at the General Meeting.
The expected timetable for the
proposed Cancellation and Re-registration is set out
below.
TRANSACTIONS IN THE ORDINARY SHARES PRIOR TO AND POST THE
PROPOSED CANCELLATION
Shareholders should note that they
are able to continue trading in the Ordinary Shares on AIM prior to
the Cancellation. Shareholders should consult with their own
independent financial adviser and/or broker should they wish to
consider selling their interests in the market prior to the
Cancellation becoming effective.
Should the Resolutions be approved
by Shareholders, the Company will implement a matched bargain
facility which would facilitate Shareholders buying and selling
Ordinary Shares on a matched bargain basis following Cancellation.
In anticipation of providing a matched bargain facility, the
Company has sought quotes from third party providers. Further
details of the Matched Bargain Facility will be communicated to
Shareholders separately in due course and made available on the
Company's website.
Shareholders should also be aware
that any such Matched Bargain Facility could be withdrawn at a
later date. Following Cancellation, the provision of a Matched
Bargain Facility will be kept under review by the Board and, in
determining whether to continue to offer a Matched Bargain
Facility, the Company shall consider expected (and communicated)
Shareholder demand for such a facility as well as the composition
of the Company's register of members and the costs to the Company
and Shareholders.
THE
GENERAL MEETING
The General Meeting will be held at
Building 5, Carrwood Park, Selby Road, Leeds, LS15 4LG
at 11.00 a.m. on 15 April 2024.
The Company has received irrevocable
undertakings from each of the Directors and their connected parties
to vote, or procure votes, in favour of the Resolutions
representing, in aggregate, Ordinary Shares. Accordingly, the
Company has received irrevocable undertakings to vote in favour of
the Resolutions representing approximately 30 per cent. of the
Company's issued share capital as at the date of this
announcement.
CURRENT TRADING AND FUTURE PROSPECTS
On 1 March 2024, the Company
announced an update on various corporate and trading matters. In
particular, the Company highlighted that the Tapir x-1 exploration
well at the Pirity Concession in Paraguay had been suspended due to
drilling difficulties. This well has now been abandoned. The
Company, along with its partners in this well, are still reviewing
what next steps they should take regarding the Pirity Licence. It
is highly probable that the Company will decide to terminate all
exploration activities in Paraguay which will lead a complete write
off of the Company's investment in that country in the current
financial year.
The Company also highlighted that it
continues to receive cash contributions from the sale of its former
subsidiary, President Petroleum S.A., a company that is ultimately
wholly beneficially owned by Peter Levine, the Company's Chairman
and largest shareholder. Approximately US$1.28 million has now been
paid to Molecular over the last four months and the Company expects
that it will continue to receive further funds over the next two
and a half years on an ad hoc basis subject to the terms and
conditions of the original sale agreement. The Company is reliant
upon these funds to satisfy the ongoing operational costs of
the business and any surplus received above those requirements will
be applied to pursue new opportunities for the benefit of all
Shareholders. In particular, the Company continues to consider the
feasibility of moving into the sustainable aviation fuel business.
It is expected that these studies will continue for the next six
months before a decision is made to allocate further, more
meaningful capital, into this business line.
The Company continues to hold an
18.4 per cent. interest in the issued share capital of Atome plc
and is encouraged by the progress that company has made.
Shareholders are reminded that this stake in Atome plc acts as
security against a loan to the Company from IYA Global Limited, a
company wholly beneficially owned by Peter Levine, the Company's
Chairman. US$12 million of this loan is outstanding as at the date
of this document and would be immediately repayable in the event
that Peter Levine or his related parties cease to be the largest
shareholder in the Company or if Peter Levine is removed as
Chairman of the Company.
As announced on 4 March 2024, Green
House, the Company's 75 per cent. carbon removal and mitigation
subsidiary, has made significant commercial progress in each of its
businesses. Moreover, Green House has received advanced assurance
for prospective EIS investment under the UK government initiative
which encourages investment in qualifying early-stage companies by
offering tax benefits to qualifying investors who subscribe for new
shares in Green House. Due to the continued challenging public
market conditions, the Directors have decided that it is not in the
best interests of the Company or its Shareholders to pursue an IPO
of Green House on AIM at this time. The Directors will consider
options for this independently run business in due
course.
GENERAL
Capitalised terms in this
announcement, unless otherwise defined, have the same meaning as
will be set out in the Circular.
A copy of the Circular and the New
Articles will be made available on the Company's website at
https://www.molecularenergiesplc.com/investors/documents-circulars/.
For more information, please
visit www.molecularenergiesplc.com
or contact:
Molecular Energies PLC
Peter Levine, Chairman
Rob Shepherd, Group FD
|
+44 (0)20 7016 7950
info@molecularenergiesplc.com
|
Cavendish Capital Markets Limited
(Nominated Adviser & Broker)
Simon Hicks
George Dollemore
|
+44 (0)20 7220 0500
|
Tavistock (Financial PR &
IR)
Simon Hudson, Nick Elwes, Saskia
Sizen
|
+44 (0)20 7920 3150
|
For the purposes of MAR, Article 2
of Commission Implementing Regulation (EU) 2016/1055 and the UK
version of such implementing regulation (as amended), the
person responsible for arranging for the release of this
Announcement on behalf of the Company is Peter Levine,
Chairman.
EXPECTED TIMETABLE OF PRINCIPAL EVENTS
Event
|
2024
|
Notice provided to the London Stock
Exchange of the proposed Cancellation
|
26
March
|
Publication and posting of this
Document and Form of
|
28
March
|
Proxy to Shareholders
|
|
Latest time and date for receipt of
Forms of Proxy in respect of the General Meeting
|
11.00 a.m.
on 11 April
|
General Meeting
|
11.00 a.m. on 15
April
|
Last day of dealings in Ordinary
Shares on AIM
|
26
April
|
Time and date of
Cancellation(3)
|
7.00 a.m.
on 29 April
|
Re-registration as a private limited
company
|
week
commencing 1 May
|
Notes:
1. References to times in this Document are to London time,
unless otherwise stated.
2. Each of the times and dates in the above timetable is subject
to change. If any of the above times and/or dates change, the
revised times and dates will be notified to Shareholders by an
announcement through a Regulatory Information Service.
3. The Cancellation requires the approval of not less than 75 per
cent. of the votes cast (in person or by proxy) by Shareholders at
the General Meeting.
The following text is
extracted from the Circular without amendment:
1.
Introduction
As announced by the Company on 28
March 2024, the Directors have concluded that it is in the best
interests of the Company and its Shareholders to cancel the
admission of the Ordinary Shares to trading on AIM. Pursuant to
Rule 41 of the AIM Rules, the Company (through its nominated
advisers, Cavendish) has notified the London Stock Exchange of the
date of the proposed Cancellation.
The Cancellation is conditional,
pursuant to Rule 41 of the AIM Rules, upon the approval of not less
than 75 per cent. of the votes cast by Shareholders (whether
present in person or by proxy) at the General Meeting, notice of
which is set out at Part 4 of this document.
Accordingly, the Company is seeking
Shareholder approval for the Cancellation, Re-registration and
adoption of the New Articles at the General Meeting, which has been
convened for 11.00 a.m. on 15 April 2024 at Carrwood Park, Selby
Road, Leeds, LS15 4LG. If the Cancellation Resolution is passed at
the General Meeting, it is anticipated that the Cancellation will
become effective at 7.00 a.m. on 29 April 2024.
The Company has received irrevocable
undertakings from certain shareholders and each of the Directors,
to vote, or procure votes, in favour of the Resolutions
representing, in aggregate, 3,741,371 Ordinary Shares.
Accordingly, the Company has
irrevocable undertakings to vote in favour of the Resolutions by
Shareholders representing approximately 30 per cent. of the
Company's issued share capital as at 27 March 2024 (being the
latest practicable date prior to publication of this
Document).
The
purpose of this Document is to seek Shareholder approval in respect
of the Resolutions, to provide information on the background and
reasons for the proposed Cancellation and the Re-registration and
associated adoption of the New Articles, to explain the
consequences of the Cancellation and the Re-registration and
associated adoption of the New Articles and provide reasons why the
Directors unanimously consider the Cancellation and the
Re-registration and associated adoption of the New Articles to be
in the best interests of the Company and its Shareholders as a
whole.
The Notice of the General Meeting is
set out in Part 4 of this Document.
In addition, and as also announced
by the Company today, the Board has reconsidered the potential
merits of the IPO of its 75 per cent. owned carbon removal and
mitigation subsidiary, Green House Capital Group plc. The Board
takes the view given the considerations in relation to Molecular
outlined below and the ongoing adverse sentiment affecting the
London capital markets that an IPO of this business at its early
stage of development is not in the best interests of the Company or
its Shareholders at the current time. The Directors will in due
course review options in relation to this independently run group
as the business becomes more mature sheltered from the public
markets. This may include separately and privately funding parts of
the Group as may be appropriate.
2. Background to and
reasons for the Cancellation and Re-registration
The Directors have conducted an
assessment of the benefits and drawbacks to the Company and its
Shareholders of retaining its quotation on AIM, and believe that
Cancellation is in the best interests of the Company and its
Shareholders as a whole.
In reaching this conclusion, the
Directors have considered the adverse share price performance of
the Company, its current market capitalisation, the perception of
the Company on AIM versus its potential, and the various potential
sources of capital available to the Company to fund its medium term
growth plans. In particular and without limit thereto, the
Directors consider:
·
that despite the best and continual efforts of the
Company to set forth its compelling investment case, its share
price has continued to fall to a level that the Board believes is
far removed from the underlying value of the Group. The Board
considers that the reasons for this include that the Company
operates and invests in territories (e.g. the southern cone of
South America) that the London capital markets does not prioritise
or fully comprehend and what the Directors perceive as the current
dysfunction of the London markets with regard to small/micro cap
companies. The Board believes that the disconnected market value is
damaging to the reputation of the Company as it seeks to engage
partners and grow its business. Accordingly, the Board believes
that Company's growth prospects are more readily accessible and
managed in a private market environment;
·
that the continued quotation on
AIM is thus unlikely to provide the Company with significantly
wider access to capital than the funding options it already has.
The Directors believe that an equity fundraise for the purpose of
either expansion or acquisition through the public markets would
not necessarily be available to the Company in the near or medium
term or if it were the Directors would not be able to recommend the
likely dilutive impact to existing shareholders. Further, Company's
existing major shareholder has indicated that he is presently
unwilling to provide the capital support to the Company on an
ongoing basis in the event that its shares remain admitted to
trading on AIM. Accordingly, the Board is of the view that there
may be greater opportunities to raise additional capital in the
private markets than remaining as a listed business;
·
there has been limited
liquidity in the Ordinary Shares for some time and, consequently,
the admission of the Ordinary Shares to trading on AIM does not
necessarily offer investors the opportunity to trade in meaningful
volumes or with frequency within an active market. With low trading
volumes, the Company's share price can move and has moved up or
down significantly following trades of disproportionately small
volumes of Ordinary Shares. In the opinion of the Directors, the
volatile share price is detrimental to the perception of the Group
amongst customers, suppliers and other partners, which, in turn,
has the potential to negatively impact its product development,
staff incentives and morale and industry reputation;
·
the considerable management time,
cost and the legal and regulatory burden associated with
maintaining the Company's admission to trading on AIM is, in the
Directors' opinion and in the light of the above, disproportionate
to the benefits of the Company's continued admission to trading on
AIM. Given the lower costs associated with private limited company
status, it is estimated that the Cancellation and Re-registration
will materially reduce the Company's recurring administrative and
adviser costs by approximately £500,000 per annum, which the
Directors believe can be better spent supporting growth in the
Group's business.
Following careful consideration, the
Directors therefore believe that it is in the best interests of the
Company and Shareholders as a whole to seek the proposed
Cancellation and Re-registration at the earliest
opportunity.
In addition, in connection with the
Re-registration, it is proposed that the New Articles be adopted to
reflect the change in the Company's status to a private limited
company. The principal effects of the Re-registration and the
adoption of the New Articles on the rights and obligations of
Shareholders and the Company are summarised in Part 2 of this
Document.
3. Process for, and
principal effects of, the Cancellation
The Directors are aware that certain
Shareholders may be unable or unwilling to hold Ordinary Shares in
the event that the Cancellation is approved and becomes effective.
Such Shareholders should consider
selling their interests in the market prior to the Cancellation
becoming effective.
Under the AIM Rules, the Company is
required to give at least 20 clear Business Days' notice of
Cancellation. Additionally, Cancellation will not take effect until
at least five clear Business Days have passed following the passing
of the Cancellation Resolution. If the Cancellation Resolution is
passed at the General Meeting, it is proposed that the last day of
trading in Ordinary Shares on AIM will be 26 April 2024 and that
the Cancellation will take effect at 7.00 a.m. on 29 April
2024.
The principal effects of the
Cancellation will include the following:
·
there will be no formal market mechanism enabling
the Shareholders to trade Ordinary Shares. Save for the Matched
Bargain Facility referred to in paragraph 4.2 below, no other
recognised market or trading facility is intended to be put in
place to facilitate the trading on the Ordinary Shares;
·
while the Ordinary Shares will
remain freely transferable, it is possible that, following the
publication of this Document, the liquidity and marketability of
the Ordinary Shares will be reduced and their value adversely
affected (however, as set out above, the Directors believe that the
existing liquidity in the Ordinary Shares is in any event
limited);
·
the Ordinary Shares may be more
difficult to sell compared to shares of companies traded on AIM (or
any other recognised market or trading exchange);
·
in the absence of a formal market and quote, it
may be difficult for Shareholders to determine the market value of
their investment in the Company at any given time;
·
the regulatory and financial
reporting regime applicable to companies whose shares are admitted
to trading on AIM will no longer apply;
·
Shareholders will no longer be afforded the
protections given by the AIM Rules, such as the requirement to be
notified of price sensitive information or certain events and the
requirement that the Company seek shareholder approval for certain
corporate actions, where applicable, including substantial
transactions, reverse takeovers, related party transactions and
fundamental changes in the Company's business, including certain
acquisitions and disposals;
·
the levels of disclosure and corporate governance
within the Company may not be as stringent as for a company quoted
on AIM;
·
the Company will no longer be subject to UK MAR
regulating inside information and other matters;
·
the Company will no longer be required to publicly
disclose any change in major shareholdings in the Company under the
Disclosure Guidance and Transparency Rules;
·
the Company will cease to have an independent
nominated adviser and broker;
·
whilst the Company's CREST facility will remain in
place immediately post the Cancellation, the Company's CREST
facility may be cancelled in the future and, although the Ordinary
Shares will remain transferable, they may cease to be transferable
through CREST (in which case, Shareholders who hold Ordinary Shares
in CREST will receive share certificates);
·
stamp duty will be due on transfers of shares and
agreements to transfer shares unless a relevant exemption or relief
applies to a particular transfer; and
·
the Cancellation and Re-registration may have
personal taxation consequences for Shareholders. Shareholders who
are in any doubt about their tax position should consult their own
professional independent tax adviser.
The
above considerations are not exhaustive, and Shareholders should
seek their own independent advice when assessing the likely impact
of the Cancellation on them.
For the avoidance of doubt, the
Company will remain registered with the Registrar of Companies in
England and Wales in accordance with and, subject to the Companies
Act, notwithstanding the Cancellation and
Re-registration.
The Company currently intends to
continue to provide certain facilities and services to Shareholders
that they currently enjoy as shareholders of an AIM company. The
Company will:
·
continue to communicate
information about the Company (including annual accounts) to its
Shareholders, as required by the Companies Act;
·
continue to hold annual general
meetings;
·
continue, for at least 12 months following the
Cancellation, to maintain its website, https://www.molecularenergiesplc.com
and social media channels and post updates on the
each from time to time, although Shareholders should be aware that
there will be no obligation on the Company to include all of the
information required under the Disclosure Guidance and Transparency
Rules, AIM Rule 26 or to update the website as required by the AIM
Rules. However, for at least 12 months following Cancellation the
Company will publish on its website and via social media any
information that the Board considers would have required
notification under Rules 10 and 11 of the AIM Rules for Companies;
and
· implement the Matched Bargain Facility which will facilitate
Shareholders buying and selling Ordinary Shares on a matched
bargain basis following Cancellation.
Alexander Moody-Stuart has confirmed
that he intends to resign as a Director of the Company from the
date of Cancellation.
The Resolutions to be proposed at
the General Meeting include the adoption of the New Articles, with
effect from the Re-registration. A summary of the principal
differences between the Current Articles and the proposed New
Articles is included in Part 2 of this Document. A copy of the New
Articles can be viewed at
https://www.molecularenergiesplc.com/investors/aim-rule-26/.
4. Transactions in the Ordinary
Shares prior to and post the proposed
Cancellation
4.1
Prior to
Cancellation
Shareholders should note that they
are able to continue trading in the Ordinary Shares on AIM prior to
Cancellation.
4.2
Dealing and settlement
arrangements
The Directors are aware that certain
Shareholders may wish to acquire or dispose of Ordinary Shares in
the Company following the Cancellation.
Therefore, the Company has made
arrangements for the Matched Bargain Facility to assist
Shareholders to trade in the Ordinary Shares to be put in place
from the day of Cancellation if the Resolution is passed. The
Matched Bargain Facility will be provided by JP Jenkins Limited
("JP Jenkins"). JP Jenkins is a liquidity venue for unlisted or
unquoted assets in companies, enabling shareholders and prospective
investors to buy and sell equity on a matched bargain basis. JP
Jenkins is a trading name of InfinitX Limited and Appointed
Representative of Prosper Capital LLP (FRN453007).
Under the Matched Bargain Facility,
Shareholders or persons wishing to acquire or dispose of Ordinary
Shares will be able to leave an indication with JP Jenkins, through
their stockbroker (JP Jenkins is unable to deal directly with
members of the public), of the number of Ordinary Shares that they
are prepared to buy or sell at an agreed price. In the event that
JP Jenkins is able to match that order with an opposite sell or buy
instruction, they would contact both parties and then effect the
bargain. Should the Cancellation become effective and the Company
put in place the Matched Bargain Facility, details will be made
available to Shareholders on the Company's website at
https://www.molecularenergiesplc.com/investors
and directly by letter or e-mail (where
appropriate).
Following Cancellation, the
provision of the Matched Bargain Facility will be kept under review
by the Board and, in determining whether to continue to offer a
Matched Bargain Facility, the Company shall consider expected (and
communicated) Shareholder demand for such a facility as well as the
composition of the Company's register of members and the costs to
the Company and Shareholders.
Peter Levine recognising that
Cancellation is not the outcome that Shareholders, including
himself, had anticipated at the time of their original investment,
has indicated, without commitment or obligation on his part, that,
in the fullness of time and subject to the passing of the
Resolutions and confirmation that the Takeover Code no longer
applies to the Company, he does not rule out making proposals to
acquire shares of any shareholders then wishing to dispose of their
holdings on terms and conditions to be mutually agreed on a matched
bargain basis from time to time.
4.3
Directors' intentions
Each of the Directors has indicated
their current intention to retain their Ordinary Shares in the
event that the Cancellation is implemented.
5. Current Trading, Strategy and
Prospects
On 1 March 2024, the Company
announced an update on various corporate and trading matters. In
particular, the Company highlighted that the Tapir x-1 exploration
well at the Pirity Concession in Paraguay had been suspended due to
drilling difficulties. This well has now been abandoned. The
Company, along with its partners in this well, are still reviewing
what next steps they should take regarding the Pirity Licence. It
is highly probable that the Company will decide to terminate all
exploration activities in Paraguay which will lead a complete write
off of the Company's investment in that country in the current
financial year.
The Company also highlighted that it
continues to receive cash contributions from the sale of its former
subsidiary, President Petroleum S.A., a company that is ultimately
wholly beneficially owned by Peter Levine, the Company's Chairman
and largest shareholder. Approximately US$1.28 million has now been
paid to Molecular over the last four months and the Company expects
that it will continue to receive further funds over the next two
and a half years on ad hoc basis subject to the terms and
conditions of the original sale agreement. The Company is reliant
upon these funds to satisfy the ongoing operational costs of the
business and any surplus received above those requirements will be
applied to pursue new opportunities for the benefit of all
Shareholders. In particular, the Company continues to consider the
feasibility of moving into the sustainable aviation fuel business.
It is expected that these studies will continue for the next six
months before a decision is made to allocate further, more
meaningful capital, into this business line.
The Company continues to hold an
18.4 per cent. interest in the issued share capital of Atome plc
and is encouraged by the progress that company has made.
Shareholders are reminded that this stake in Atome plc acts as
security against a loan to the Company from IYA Global Limited, a
company wholly beneficially owned by Peter Levine, the Company's
Chairman. US$12 million of this loan is outstanding as at the date
of this document and would be immediately repayable in the event
that Peter Levine or his related parties cease to be the largest
shareholder in the Company or if Peter Levine is removed as
Chairman of the Company.
As announced on 4 March 2024, Green
House, the Company's 75 per cent. carbon removal and mitigation
subsidiary, has made significant commercial progress in each of its
businesses. Moreover, Green House has received advanced assurance
for prospective EIS investment under the UK government initiative
which encourages investment in qualifying early-stage companies by
offering tax benefits to qualifying investors who subscribe for new
shares in Green House. Due to the continued challenging public
market conditions, the Directors have decided that it is not in the
best interests of the Company or its Shareholders to pursue an IPO
of Green House on AIM at this time. The Directors will consider
options for this independently run business in due
course.
6. Re-registration
As set out above, following the
Cancellation, the Directors believe that the requirements and
associated costs of the Company maintaining its public company
status will be difficult to justify and that the Company will
benefit from the more flexible requirements and lower costs
associated with private limited company status. It is therefore
proposed to re-register the Company as a private limited company.
In connection with the Re-registration, it is proposed that the New
Articles be adopted to reflect the change in the Company's status
to a private limited company. The principal effects of the
Re-registration and the adoption of the New Articles on the rights
and obligations of Shareholders and the Company are summarised in
Part 2 of this Document.
An application will be made to the
Registrar of Companies for the Company to be re-registered as a
private limited company. Re-registration will take effect when the
Registrar of Companies issues a certificate of incorporation on
Re-registration. The Registrar of Companies will issue the
certificate of incorporation on Re-registration when it is
satisfied that no valid application can be made to cancel the
resolution to re-register as a private limited company or that any
such application to cancel the resolution to re-register as a
private limited company has been determined and confirmed by the
Court.
7. Takeover
Code
The Takeover Code applies to all
offers for companies which have their registered offices in the
United Kingdom, the Channel Islands or the Isle of Man if any of
their equity share capital or other transferable securities
carrying voting rights are admitted to trading on a UK regulated
market or a UK multilateral trading facility or on any stock
exchange in the Channel Islands or the Isle of Man. The Takeover
Code also applies to all offers for companies (both public and
private) which have their registered offices in the United Kingdom,
the Channel Islands or the Isle of Man and which are considered by
the Panel to have their place of central management and control in
the United Kingdom, the Channel Islands or the Isle of Man, but in
relation to private companies only if one of a number of conditions
is met - for example, if the company's shares were admitted to
trading on a UK regulated market or a UK multilateral trading
facility or on any stock exchange in the Channel Islands or the
Isle of Man at any time in the preceding ten years.
If the Cancellation and
Re-registration are approved by Shareholders at the General
Meeting, the Company will be re-registered as a private company and
its securities will no longer be admitted to trading on a regulated
market or a multilateral trading facility in the United Kingdom. In
these circumstances, the Takeover Code will only apply to the
Company if it is considered by the Panel to have its place of
central management and control in the United Kingdom, the Channel
Islands or the Isle of Man. This is known as the "residency test".
In determining whether the residency test is satisfied, the Panel
has regard primarily to whether a majority of a company's directors
are resident in these jurisdictions.
The Panel has confirmed to the
Company that, on the basis of the current residency of the
Directors and in light of the proposed resignation of Alexander
Moody-Stuart, the Company will not have its place of central
management and control in the United Kingdom following this
resignation and the Cancellation and Re-registration. As a result,
in the event that the Cancellation and Re-registration are approved
by Shareholders at the General Meeting and become effective, the
Takeover Code will cease to apply to the Company and Shareholders
will no longer be afforded the protections provided by the Takeover
Code. This includes, but is not limited to, the requirement for a
mandatory cash offer to be made if either:
·
a person acquires an interest
in shares which, when taken together with the shares in which
persons acting in concert with it are interested, increases the
percentage of shares carrying voting rights in which it is
interested to 30 per cent. or more; or
·
a person, together with persons
acting in concert with it, is interested in shares which in the
aggregate carry not less than 30 per cent. of the voting rights of
a company but does not hold shares carrying more than 50 per cent.
of such voting rights and such person, or any person acting in
concert with it, acquires an interest in any other shares which
increases the percentage of shares carrying voting rights in which
it is interested.
The Company notes that Peter Levine
has notified the Company, without commitment, that, subject to the
passing of the Resolutions and confirmation that the Takeover Code
no longer applies to the Company, he may make proposals to acquire
shares of any shareholders then wishing to dispose of their
holdings on terms and conditions to be mutually agreed on a matched
bargain basis from time to time. Shareholders should be aware that, in such
circumstances and, if as a consequence the interests of Peter
Levine and those persons acting in concert with him carry 30 per
cent. or more of the voting rights of the Company, Peter Levine and
those persons acting in concert with him would not be required to
make a mandatory general cash offer to all
Shareholders.
A summary of the protections
afforded to Shareholders by the Takeover Code which will be lost by
virtue of the above proposals is set out in Part 3 of this
Document.
8. Process for
Cancellation
Under the AIM Rules, it is a
requirement that the Cancellation must be approved by Shareholders
holding not less than 75 per cent. of votes cast by Shareholders at
the General Meeting. Accordingly, the Notice of General Meeting set
out in Part 4 of this Document contains a special resolution to
approve the Cancellation.
Furthermore, Rule 41 of the AIM
Rules requires any AIM company that wishes the London Stock
Exchange to cancel the admission of its shares to trading on AIM to
notify shareholders and to separately inform the London Stock
Exchange of its preferred cancellation date at least 20 Business
Days prior to such date. In accordance with AIM Rule 41, the
Directors have notified the London Stock Exchange of the Company's
intention, subject to the Cancellation Resolution being passed at
the General Meeting, to cancel the Company's admission of the
Ordinary Shares to trading on AIM on 29 April 2024. Accordingly, if
the Cancellation Resolution is passed, the Cancellation will become
effective at 7.00 a.m. on 29 April 2024. If the Cancellation
becomes effective, Cavendish will cease to be nominated adviser of
the Company and the Company will no longer be required to comply
with the AIM Rules.
9. General
Meeting
The General Meeting will be held at
Carrwood Park, Selby Road, Leeds, LS15 4LG at 11.00 a.m. on 15
April 2024.
Resolution 1 to be proposed at the
General Meeting is a special resolution to approve the
Cancellation.
Resolution 2 to be proposed at the
General Meeting is a special resolution to re-register the Company
as a private company and to approve the adoption by the Company of
new articles of association.
Resolution 1 is not conditional on
Resolution 2 but Resolution 2 is conditional on Resolution
1.
10. Action to be taken in
relation to the General Meeting
To be valid, the accompanying Form
of Proxy for use in connection with the General Meeting must be
completed, signed and returned in accordance with the instructions
printed thereon so as to be received by the Company's Registrars,
Equiniti Limited, Aspect House, Spencer Road, Lancing, West Sussex,
BN99 6DA as soon as possible and, in any event, by no later than
11.00 a.m. on 11 April 2024 (or, if the General Meeting is
adjourned, 48 hours before the time fixed for the adjourned meeting
excluding non-working days).
Where Ordinary Shares are held in
CREST, via CREST. To be valid, notwithstanding the method of
appointment, a proxy appointment must be returned/transmitted so as
to be received by the Registrars as soon as possible and, in any
event, by no later than 11.00 a.m. on 11 April 2024 (or, if the
General Meeting is adjourned, 48 hours before the time fixed for
the adjourned meeting excluding non-working days). For further
details on how to submit a proxy appointment, please see the notes
to the Notice of General Meeting at the end of this
Document.
11. Recommendation
The Directors consider that the
Cancellation and the Re-registration and adoption of the New
Articles are in the best interests of the Company and its
Shareholders as a whole and, therefore, unanimously recommend that
you vote in favour of the Resolutions at the General Meeting as
each of the Directors intends to vote, or procure the vote, in
respect of, in aggregate, 3,070,594 Ordinary Shares to which they
are beneficially entitled.
-ends-